Steven Perrin

1.2k citations

17 papers · 656 indexed · h-index 12

Impact in

Neurology top 5%
- Amyotrophic Lateral Sclerosis Research
- Parkinson's Disease Mechanisms and Treatments
Immunology top 10%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune Response and Inflammation

Papers in ⓘ

Neurology 10
- Amyotrophic Lateral Sclerosis Research 10
- Parkinson's Disease Mechanisms and Treatments 3
Molecular Biology 7
- Single-cell and spatial transcriptomics 3
- RNA Research and Splicing 2
- Molecular Biology Techniques and Applications 2

Co-authors: Fernando G. Vieira (8 shared papers)Alan Gill (7 shared papers)Norm Allaire (3 shared papers)Kenneth Thompson (6 shared papers)Joshua D. Kidd (6 shared papers)Jeffrey L. Browning (1 shared paper)Jane Hunt (1 shared paper)Roy A. Fava (1 shared paper)
Journals: PLoS ONE (4 papers)Genomics (2 papers)Muscle & Nerve (1 paper)Nature Genetics (1 paper)PLoS Medicine (1 paper)
Partner nations: United States Canada

In The Last Decade

Steven Perrin

17 papers receiving 640 citations

Peers

Countries citing papers authored by Steven Perrin

Since Specialization

Citations

This map shows the geographic impact of Steven Perrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Perrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Perrin more than expected).

Fields of papers citing papers by Steven Perrin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Perrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Perrin. The network helps show where Steven Perrin may publish in the future.

Co-authors

The 25 scholars most cited alongside Steven Perrin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven Perrin Line = papers co-authored together Steven Perrin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Lymphotoxin-β Receptor Signaling Is Required for the Homeostatic Control of HEV Differentiation and Function Immunity ·Jeffrey L. Browning, Norm Allaire, Apinya Ngam-ek, Evangelia Notidis, Jane Hunt, Steven Perrin, Roy A. Fava	2005	213
2	From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis Nature Genetics ·John Lincecum, Fernando G. Vieira, Monica Z. Wang, Kenneth Thompson, Gerald S De Zutter, Joshua D. Kidd, Andrew Moreno, Ricardo Sànchez, Isarelis J Carrion, Beth Levine, Bashar M. Al‐Nakhala, Shawn M Sullivan, Alan Gill, Steven Perrin	2010	96
3	No Benefit from Chronic Lithium Dosing in a Sibling-Matched, Gender Balanced, Investigator-Blinded Trial Using a Standard Mouse Model of Familial ALS PLoS ONE ·Alan Gill, Joshua D. Kidd, Fernando G. Vieira, Kenneth Thompson, Steven Perrin	2009	66
4	Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS PLoS ONE ·Fernando G. Vieira, Qinggong Ping, Andy J. Moreno, Joshua D. Kidd, Kenneth Thompson, Bingbing Jiang, John Lincecum, Monica Z. Wang, Gerard S. De Zutter, Valerie R. Tassinari, Beth Levine, Theo Hatzipetros, Alan Gill, Steven Perrin	2015	64
5	Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability Muscle & Nerve ·James D. Berry, Sabrina Paganoni, Nazem Atassi, Eric A. Macklin, Namita Goyal, Michael H. Rivner, Ericka Simpson, Stanley H. Appel, Daniela Grasso, Nicte I. Mejia, Farrah J. Mateen, Alan Gill, Fernando G. Vieira, Valerie R. Tassinari, Steven Perrin	2017	42
6	The Inhibition of CD40/CD154 Costimulatory Signaling in the Prevention of Renal Transplant Rejection in Nonhuman Primates: A Systematic Review and Meta Analysis Frontiers in Immunology ·Steven Perrin, Marianne Magill	2022	35
7	CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits IBRO Reports ·Fernando G. Vieira, Theo Hatzipetros, Kenneth Thompson, Andy J. Moreno, Joshua D. Kidd, Valerie R. Tassinari, Beth Levine, Steven Perrin, Alan Gill	2017	32
8	A machine-learning based objective measure for ALS disease severity npj Digital Medicine ·Fernando G. Vieira, Subhashini Venugopalan, Alan Premasiri, Maeve McNally, Aren Jansen, Kevin McCloskey, Michael P. Brenner, Steven Perrin	2022	24
9	Dexpramipexole Is Ineffective in Two Models of ALS Related Neurodegeneration PLoS ONE ·Fernando G. Vieira, Eva LaDow, Andy J. Moreno, Joshua D. Kidd, Beth Levine, Kenneth Thompson, Alan Gill, Steven Finkbeiner, Steven Perrin	2014	23
10	The Zebrafish Swimbladder: A Simple Model for Lung Elastin Injury and Repair Connective Tissue Research ·Steven Perrin, Celeste B. Rich, Shirley M. Morris, Phillip J. Stone, Judith Ann Foster	1999	16
11	Developmental Regulation of Elastin Gene Expression Critical Reviews in Eukaryotic Gene Expression ·Steven Perrin, Judith Ann Foster	1997	15
12	Nondestructive Quality Control for Microarray Production BioTechniques ·Jeffrey R. Shearstone, Norman Allaire, Michael E. Getman, Steven Perrin	2002	13
13	Accurate and precise transcriptional profiles from 50 pg of total RNA or 100 flow-sorted primary lymphocytes Genomics ·Jeffrey R. Shearstone, Norm Allaire, Juanita Campos‐Rivera, Sambasiva P. Rao, Steven Perrin	2006	8
14	Application of functional genomic technologies in a mouse model of retinal degeneration Genomics ·Jeffrey R. Shearstone, Yang E. Wang, Amanda Clement, Norm Allaire, Chunhua Yang, Dane Worley, John P. Carulli, Steven Perrin	2004	5
15	Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial PLoS Medicine ·Steven Perrin, Shafeeq Ladha, Nicholas J. Maragakis, Michael H. Rivner, Jonathan Katz, Angela Genge, Nicholas Olney, Dale J. Lange, Daragh Heitzman, Cynthia Bodkin, Omar Jawdat, Namita Goyal, Jeffrey D. Bornstein, Carmen Mak, Stanley H. Appel, Sabrina Paganoni	2024	2
16	A Phase IIa Double-Blind, Placebo-Controlled Study to Evaluate the Safety of Oral Fingolimod In Patients with Amyotrophic Lateral Sclerosis (ALS) (P7.067) Neurology ·James D. Berry, Sabrina Paganoni, Nazem Atassi, Namita Goyal, Michael H. Rivner, Ericka Simpson, Stanley H. Appel, Daniela Grasso, Nicte I. Mejia, Farrah J. Mateen, Merit Cudkowicz, Steven Perrin	2015	1
17	PERK modulation, with GSK2606414, Sephin1 or salubrinal, failed to produce therapeutic benefits in the SOD1G93A mouse model of ALS PLoS ONE ·Fernando G. Vieira, Valerie R. Tassinari, Joshua D. Kidd, Andrew Moreno, Kenneth Thompson, Steven Perrin, Alan Gill, Theo Hatzipetros	2024	1

About Steven Perrin

Steven Perrin is a scholar working on Neurology, Molecular Biology, Genetics, Immunology and Cell Biology, having authored 17 papers that have together received 656 indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (10 papers), Neurogenetic and Muscular Disorders Research (5 papers), Single-cell and spatial transcriptomics (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers), Connective tissue disorders research (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers), RNA Research and Splicing (2 papers) and Molecular Biology Techniques and Applications (2 papers). The work is most often cited by research in Neurology (225 citations), Immunology (222 citations), Genetics (97 citations), Neurology (67 citations) and Aging (8 citations). Steven Perrin has collaborated with scholars based in United States and Canada. Frequent co-authors include Fernando G. Vieira, Alan Gill, Norm Allaire, Kenneth Thompson, Joshua D. Kidd, Jeffrey L. Browning, Jane Hunt, Roy A. Fava, Apinya Ngam-ek and Beth Levine. Their work appears in journals such as PLoS ONE, Genomics, Muscle & Nerve, Nature Genetics and PLoS Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact